25.07.31 (¸ñ) 09:58

Dailypharm

X
"ó¹æÇàÅ Å뺸·Ð ÇѰè"..½Ç¸í°ø°³ ½Åȣź
±èÅÂÇü ±âÀÚ 2005-04-27 13:24:53
"ó¹æÇàÅ Å뺸·Ð ÇѰè"..½Ç¸í°ø°³ ½Åȣź
±èÅÂÇü ±âÀÚ 2005-04-27 13:24:53
[DPÅäÇÈ] ÁÖ»çó¹æ »óÀ§ 25% 5¿ù °øÇ¥..."75%´Â °úÀ×Àΰ¡" ºÒ¸¸



|´º½ººÐ¼®=½ÉÆò¿ø ÀÇ·á±â°ü ÁÖ»çÁ¦ 󹿷ü °ø°³|

°Ç°­º¸Çè½É»çÆò°¡¿øÀÌ 26ÀÏ Áß¾ÓÆò°¡À§¿øÈ¸¸¦ ¿­¾î ÁÖ»çó¹æÀÌ ¾çÈ£ÇÑ º´ÀÇ¿ø ¸í´ÜÀ» °ø°³Å°·Î °áÁ¤ÇÑ °ÍÀº 4³â°£ ½Ç½ÃÇØ¿Â ¾àÁ¦ ÀûÁ¤¼º Æò°¡°á°ú¸¦ Àû±Ø Ȱ¿ëÇϰڴٴ ¶æÀ¸·Î ÇØ¼®µÈ´Ù.

±âÁ¸ Æò°¡°á°ú¸¦ ÀÇ·á±â°ü¿¡ Å뺸¸¸ ÇÏ´Â ¼Ò±ØÀûÀÎ ¹æ¹ýÀÌ ¾Æ´Ï¶ó º´ÀÇ¿øÀÇ ½Ç¸íÀ» °ø°³ÇÏ´Â Àû±Ø¼ºÀ» ¶ì°Ú´Ù´Â °ÍÀÌ´Ù.

½ÉÆò¿øÀº Áß¾ÓÆò°¡À§¿øÈ¸°¡ ¸í´Ü°ø°³¸¦ °áÁ¤ÇÔ¿¡ µû¶ó ÀÇ¿ø 5,098°÷°ú º´¿ø 260°÷(2004³â 4/4ºÐ±â)ÀÇ ½Ç¸íÀ» ³»´Þ °øÇ¥ÇÑ´Ù´Â ³»ºÎ ¹æÄ§À» ¼¼¿î °ÍÀ¸·Î ÀüÇØÁ³´Ù.

"ÁÖ»ç󹿷ü °ø°³´Â ±¹¹Î ¼±ÅÃ±Ç È®´ë"

½ÉÆò¿ø °ü°èÀÚ´Â ÀÌ¿Í °ü·Ã ¡°Ã³¹æ·ü °ø°³¹æ½ÄÀ» µÑ·¯½Î°í ³í¶õÀÌ ¸¹¾ÒÁö¸¸ 󹿷üÀÌ ¾çÈ£ÇÑ °÷ºÎÅÍ °ø°³ÇÏ´Â Æ÷ÁöƼºê ¹æ½ÄÀ» äÅÃÇß´Ù¡±¸é¼­ ¡°ÀÇ·á°è°¡ ¿ì·ÁÇÏ´Â ºñ³­À̳ª ȯÀÚ Áø·áÀÇ Â÷ÁúÀº ¿ì·ÁµÇÁö ¾ÊÀ» °Í¡±À̶ó°í ¸»Çß´Ù.

½ÉÆò¿øÀÇ ¶Ç ´Ù¸¥ °ü°èÀÚ´Â ¡°ÁÖ»çÁ¦ 󹿷üÀÌ ³·°í ³ôÀº ÀÇ·á±â°üÀ» ¼±ÅÃÇÏ´Â ¹®Á¦´Â °á±¹ ¼ÒºñÀÚµéÀÌ ÆÇ´ÜÇØ¾ß ÇÒ ¹®Á¦¡±¶ó°í °­Á¶Çß´Ù.

»ç½Ç Áß¾ÓÆò°¡À§´Â ÀÇ·á±â°ü ¸í´Ü°ø°³¸¦ µÑ·¯½Î°í ÀÇ·á°è ´ëÇ¥¿Í ¼ÒºñÀÚ ´Üü°£ °ø¹æÀ» ¹úÀÎ °ÍÀ¸·Î ÀüÇØÁ³´Ù.

¸í´Ü°ø°³¸¦ ÃÖ¼ÒÈ­ÇÏ·Á´Â ÀÇ·á°èÀÇ ÁÖÀå¿¡ ½Ã¹Î´ÜüµéÀº ÁÖ»çÁ¦ 󹿷üÀÌ ³ôÀº ÀÇ·á±â°üÀ» °ø°³ÇØ¾ß ÇÑ´Ù´Â ÀÔÀåÀ¸·Î ¸Â¼± °ÍÀÌ´Ù.

ÀÇ»çÇùȸ ¹ÚÈ¿±æ ºÎȸÀåÀº ¡°½ÇÁ¦ Áֻ縦 ¸¹ÀÌ ¾²°í Àû°Ô ¾²´Â °Í¿¡ ´ëÇÑ Æò°¡±âÁØÀÌ ¸íÈ®ÇÏÁö ¾Ê´Ù¡±¸é¼­ ¡°ÁÖ»çÁ¦ 󹿱âÁØÀº °¢ ³ª¶óÀÇ È¯°æ°ú ¹®È­¿¡ µû¶ó Á¤ÇØÁ®¾ß ÇÑ´Ù¡±°í ÁÖÀåÇß´Ù.

"¼öÄ¡ÅëÇÑ ÀÏ·üÀûÀÎ °ø°³¿£ ¹Ý´ë"

¹Ú ºÎȸÀåÀº ÀÌ¾î ¡°ÀÏ·üÀûÀÎ ¼öÄ¡¸¦ °ø°³ÇÏ´Â °Í¿¡´Â ¹Ý´ëÇÑ´Ù¡±¸ç ¸í´Ü°ø°³ °áÁ¤¿¡ ºÒ¸¸À» Ç¥ÃâÇß´Ù.

ÀÇ·á°è´Â ¶ÇÇÑ Ã³¹æ·üÀÌ ¾çÈ£ÇÑ ÀÇ·á±â°üÀÇ ¸í´ÜÀ» °ø°³ÇÏ´Â Æ÷ÁöƼºê ¹æ½ÄÀ» ÃëÇÏ´õ¶óµµ °á±¹ ¸í´Ü¿¡ ºüÁø 75%´Â ÁÖ»çÁ¦¸¦ °úÀ×ó¹æÇÏ´Â °ÍÀ¸·Î ¿ÀÀÎÇÑ´Ù¸ç °á±¹ ÀÇ·á±â°ü¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ̶ó°í ÁÖÀåÇØ¿Ô´Ù.

ÇÏÁö¸¸ ½Ã¹Î´Üü¿Í ½ÉÆò¿øÀÇ ÀÔÀåÀº ÀÌ¿Í ´Ù¸£´Ù.

¼Ò½Ã¸ðÀÇ ±èÀÚÇý »ç¹«ÃÑÀåÀº ¡°½Ç¸í¸¦ °ø°³ÇØ¾ß ÇÑ´Ù´Â ¿øÄ¢¿¡´Â ÀÌ¹Ì ÇÕÀÇÇß´Ù¡±¸é¼­ ¡°¹®Á¦´Â ¸í´ÜÀ» °ø°³ÇÑ´Ù°í ÇØ¼­ ÁÖ»çÁ¦ ó¹æ °¨¼ÒÈ¿°ú¸¦ °ÅµÑ °ÍÀ̶ó°í »ý°¢ÇÏÁö ¾Ê´Â´Ù¡±°í ÀüÁ¦Çß´Ù.

±è »ç¹«ÃÑÀåÀº µû¶ó¼­ ¡°¸í´Ü °ø°³ÀÌÈÄ¿¡ ÀÇÇù ÀÚüÀûÀ¸·Î ÀÚÀ²ÀûÀÎ ³ë·ÂÀÌ º´ÇàµÅ¾ß ÇÑ´Ù¡±¸é¼­ ¡°½Ã¹Î´Üüµéµµ Áö¼ÓÀûÀÎ Ä·ÆäÀÎÀ» ¹ú¿© ³ª°¡°Ú´Ù¡±°í µ¡ºÙ¿´´Ù.

½ÉÆò¿ø °ü°èÀÚ´Â ¡°È¯ÀÚÀÇ ±¸¼º, Áø·á°ú µîÀ» °¨¾ÈÇ߱⠶§¹®¿¡ ÀÚ·á¿¡ ´ëÇÑ ½Å·Ú¼ºÀº ÀÌ¹Ì È®º¸µÈ »óÅ¡±¶ó°í ÀüÁ¦ÇÑ µÚ ¡°ÀÇ»çµéÀÇ ÁÖ»ç󹿷üÀÌ ÁÙÁö ¾ÊÀ» °æ¿ì¿¡´Â Æ÷ÁöƼºê ¹æ½ÄÀÌ °í·ÁµÉ °Í¡±À̶ó°í ¿¹»óÇß´Ù.

À̹ø ÁÖ»çó¹æ °ø°³´Â ÀÚ·áÀÇ ½Å·Úµµ µîÀ» ¹®Á¦»ï¾Ò´ø ÀÇ·á°èÀÇ ¹Ý´ë ³í¸®¸¦ ÀÇ·á¼ÒºñÀÚÀÇ ¾Ë±Ç¸® ¶ó´Â ´ëÀǸíºÐÀÌ ¿ì¼±ÇÑ´Ù´Â »ç½ÇÀ» º¸¿©Áá´Ù.

CT, Á¦¿ÕÀý°³µî ½Ç¸í°ø°³ ¸íºÐ È®º¸

µû¶ó¼­ ½É»çÆò°¡¿øÀº À̹ø °áÁ¤À¸·Î ÀÎÇØ ÇöÀç ÁøÇàÁßÀÎ Àç¿ÕÀý°³, CT, Ç×»ýÁ¦, °í°¡¾à, ºÎ½ÅÇÇÁúÈ£¸£¸óÁ¦ µî ÀϺΠÆò°¡Ç׸ñÀÇ °æ¿ì ÀÚ·áÀÇ °´°ü¼º¸¸ È®º¸µÈ´Ù¸é ¾ðÁ¦µçÁö °ø°³ÇÒ ¼ö ÀÖ´Â ¸íºÐÀ» È®º¸ÇÑ ¼ÀÀÌ´Ù.

°á±¹ ÁÖ»çó¹æ °ø°³´Â ÀûÁ¤Áø·á¸¦ À¯µµÇϱâ À§ÇÑ Æò°¡¹æ¹ý °¡¿îµ¥ ¡®½Ç¸í°ø°³¡¯¸¦ ¾Ë¸®´Â ½ÅȣźÀÎ °ÍÀÌ´Ù.

¿ä¾ç±Þ¿© ÀûÁ¤¼ºÆò°¡°¡ ¼Ò±ØÀû Å뺸¹æ½Ä¿¡¼­ ½Ç¸í°ø°³¶ó´Â ¡°Ë´Ù¸®¸¦ °ÅÃÄ Áø·áºñ¸¦ °¡°¨Áö±ÞÇÏ´Â ¹æ¾Èµµ ÃßÁøÇÒ °ÍÀÎÁö ÇâÈÄ ±ÍÃß°¡ ÁÖ¸ñµÈ´Ù.
±èÅÂÇü ±âÀÚ (thkim@dailypharm.com) ±âÀÚÀÇ ´Ù¸¥±â»ç º¸±â
  • Àμâ
  • īī¿ÀÅå
  • ÆäÀ̽ººÏ
  • Æ®À§ÅÍ
  • 1
µ¶ÀÚÀǰß
1
À͸íÀÇ°ß ¾²±â | ½Ç¸íÀǰ߾²±â ¿î¿µ±ÔÄ¢
´Ý±â

´ñ±Û ¿î¿µ¹æ½ÄÀº

´ñ±ÛÀº ½Ç¸í°ÔÀç¿Í À͸í°ÔÀç ¹æ½ÄÀÌ ÀÖÀ¸¸ç, ½Ç¸íÀº À̸§°ú ¾ÆÀ̵𰡠³ëÃâµË´Ï´Ù. À͸íÀº ÇʸíÀ¸·Î µî·Ï °¡´ÉÇϸç, ´ë´ñ±ÛÀº À͸íÀ¸·Î µî·Ï °¡´ÉÇÕ´Ï´Ù.

´ñ±Û ³ëÃâ¹æ½ÄÀº

»õ·Î¿î ´ñ±ÛÀ» ¿Ã¸®´Â ÀϹÝȸ¿øÀº ´ñ±ÛÀÇ ÇÏ´Ü¿¡ ½Ç½Ã°£ ³ëÃâµË´Ï´Ù.

´ñ±ÛÀÇ »èÁ¦ ±âÁØÀº

´ÙÀ½ÀÇ °æ¿ì »çÀü Å뺸¾øÀÌ »èÁ¦ÇÏ°í ¾ÆÀ̵ð ÀÌ¿ëÁ¤Áö ¶Ç´Â ¿µ±¸ °¡ÀÔÁ¦ÇÑÀÌ µÉ ¼öµµ ÀÖ½À´Ï´Ù.

  • ÀúÀ۱ǡ¤ÀÎ°Ý±Ç µî ŸÀÎÀÇ ±Ç¸®¸¦ Ä§ÇØÇÏ´Â °æ¿ì

    »ó¿ë ÇÁ·Î±×·¥ÀÇ µî·Ï°ú °ÔÀç, ¹èÆ÷¸¦ ¾È³»ÇÏ´Â °Ô½Ã¹°

    ŸÀÎ ¶Ç´Â Á¦3ÀÚÀÇ ÀúÀÛ±Ç ¹× ±âŸ ±Ç¸®¸¦ Ä§ÇØÇÑ ³»¿ëÀ» ´ãÀº °Ô½Ã¹°

  • ±Ù°Å ¾ø´Â ºñ¹æ¡¤¸í¿¹¸¦ ÈѼÕÇÏ´Â °Ô½Ã¹°

    ƯÁ¤ ÀÌ¿ëÀÚ ¹× °³Àο¡ ´ëÇÑ ÀνŠ°ø°ÝÀûÀÎ ³»¿ëÀÇ ±Û ¹× Á÷Á¢ÀûÀÎ ¿å¼³ÀÌ »ç¿ëµÈ °æ¿ì

    ƯÁ¤ Áö¿ª ¹× Á¾±³°£ÀÇ °¨Á¤´ë¸³À» Á¶ÀåÇÏ´Â ³»¿ë

    »ç½Ç È®ÀÎÀÌ ¾ÈµÈ ¼Ò¹®À» À¯Æ÷ ½ÃŰ´Â °æ¿ì

    ¿å¼³°ú ºñ¾î, ¼Ó¾î¸¦ ´ãÀº ³»¿ë

    Á¤´ç¹ý ¹× °øÁ÷¼±°Å¹ý, °ü°è ¹ý·É¿¡ ÀúÃ˵Ǵ °æ¿ì(¼±°üÀ§ ¿äû ½Ã Áï½Ã »èÁ¦)

    ƯÁ¤ Áö¿ªÀ̳ª ´Üü¸¦ ºñÇÏÇÏ´Â °æ¿ì

    ƯÁ¤ÀÎÀÇ ¸í¿¹¸¦ ÈѼÕÇÏ¿© ÇØ´çÀÎÀÌ »èÁ¦¸¦ ¿äûÇÏ´Â °æ¿ì

    ƯÁ¤ÀÎÀÇ °³ÀÎÁ¤º¸(Áֹεî·Ï¹øÈ£, ÀüÈ­, »ó¼¼ÁÖ¼Ò µî)¸¦ ¹«´ÜÀ¸·Î °Ô½ÃÇÏ´Â °æ¿ì

    ŸÀÎÀÇ ID ȤÀº ´Ð³×ÀÓÀ» µµ¿ëÇÏ´Â °æ¿ì

  • °Ô½ÃÆÇ Ư¼º»ó Á¦ÇѵǴ ³»¿ë

    ¼­ºñ½º ÁÖÁ¦¿Í ¸ÂÁö ¾Ê´Â ³»¿ëÀÇ ±ÛÀ» °ÔÀçÇÑ °æ¿ì

    µ¿ÀÏ ³»¿ëÀÇ ¿¬¼Ó °ÔÀç ¹× ¿©·¯ ±â»ç¿¡ Áߺ¹ °ÔÀçÇÑ °æ¿ì

    ºÎºÐÀûÀ¸·Î º¯°æÇÏ¿© ¹Ýº¹ °ÔÀçÇÏ´Â °æ¿ìµµ Æ÷ÇÔ

    Á¦¸ñ°ú °ü·Ã ¾ø´Â ³»¿ëÀÇ °Ô½Ã¹°, Á¦¸ñ°ú º»¹®ÀÌ ¹«°üÇÑ °æ¿ì

    µ·¹ú±â ¹× Á÷¡¤°£Á¢ »ó¾÷Àû ¸ñÀûÀÇ ³»¿ëÀÌ Æ÷ÇÔµÈ °Ô½Ã¹°

    °Ô½Ã¹° Àбâ À¯µµ µîÀ» À§ÇØ ³»¿ë°ú ¹«°üÇÑ Á¦¸ñÀ» »ç¿ëÇÑ °æ¿ì

  • ¼ö»ç±â°ü µîÀÇ °ø½ÄÀûÀÎ ¿äûÀÌ ÀÖ´Â °æ¿ì

  • ±âŸ»çÇ×

    °¢ ¼­ºñ½ºÀÇ Çʿ伺¿¡ µû¶ó ¹Ì¸® °øÁöÇÑ °æ¿ì

    ±âŸ ¹ý·ü¿¡ ÀúÃ˵Ǵ Á¤º¸ °ÔÀ縦 ¸ñÀûÀ¸·Î ÇÒ °æ¿ì

    ±âŸ ¿ø¸¸ÇÑ ¿î¿µÀ» À§ÇØ ¿î¿µÀÚ°¡ ÇÊ¿äÇÏ´Ù°í ÆÇ´ÜµÇ´Â ³»¿ë

  • »ç½Ç °ü°è È®ÀÎ ÈÄ »èÁ¦

    ÀúÀÛ±ÇÀڷκÎÅÍ Çã¶ô¹ÞÁö ¾ÊÀº ³»¿ëÀ» ¹«´Ü °ÔÀç, º¹Á¦, ¹èÆ÷ÇÏ´Â °æ¿ì

    ŸÀÎÀÇ ÃÊ»ó±ÇÀ» Ä§ÇØÇϰųª °³ÀÎÁ¤º¸¸¦ À¯ÃâÇÏ´Â °æ¿ì

    ´ç»ç¿¡ Á¦°øÇÑ ÀÌ¿ëÀÚÀÇ Á¤º¸°¡ ÇãÀ§ÀÎ °æ¿ì (ŸÀÎÀÇ ID, ºñ¹Ð¹øÈ£ µµ¿ë µî)

  • ¡ØÀÌ»óÀÇ ³»¿ëÁß ÀϺΠ»çÇ׿¡ Àû¿ëµÉ °æ¿ì ÀÌ¿ë¾à°ü ¹× °ü·Ã ¹ý·ü¿¡ ÀÇÇØ Á¦À縦 ¹ÞÀ¸½Ç ¼öµµ ÀÖÀ¸¸ç, ¹Î¡¤Çü»ç»ó ó¹úÀ» ¹ÞÀ» ¼öµµ ÀÖ½À´Ï´Ù.

    ¡ØÀ§¿¡ ¸í½ÃµÇÁö ¾ÊÀº ³»¿ëÀÌ´õ¶óµµ ºÒ¹ýÀûÀÎ ³»¿ëÀ¸·Î ÆÇ´ÜµÇ°Å³ª µ¥Àϸ®ÆÊ ¼­ºñ½º¿¡ ¹Ù¶÷Á÷ÇÏÁö ¾Ê´Ù°í ÆÇ´ÜµÇ´Â °æ¿ì´Â ¼± Á¶Ä¡ ÀÌÈÄ º» °ü¸® ±âÁØÀ» ¼öÁ¤ °ø½ÃÇϰڽÀ´Ï´Ù.

    ¡Ø±âŸ ¹®ÀÇ »çÇ×Àº µ¥Àϸ®ÆÊ ¿î¿µÀÚ¿¡°Ô ¿¬¶ôÁֽʽÿÀ. ¸ÞÀÏ ÁÖ¼Ò´Â dailypharm@dailypharm.comÀÔ´Ï´Ù.

Ãֽżø Âù¼º¼ø ¹Ý´ë¼ø
  • 2005.04.28 00:41:37 ¼öÁ¤ | »èÁ¦

    ¡¡

    It is really sad that physicians need to be forced to be compliant with the policy in this way. However, it is not the policy at all. Rather, it is more scientific and evidence-based. IV drugs are required only in those circumstances: 1. There is no oral formulations available 2. Patients cannot eat food (GI problems, some neurological diseases etc) 3. When rapid onset of action of the drug is required (seizure, severe infection etc) In other cases, oral administration has at least comparable efficacy to IV (even in infections shown by many clinical studies) and has some advantages: 1. Avoid high peaks that are associated with more side effects 2. Avoid injection-related complications including infection and inflammation 3. Cheap In addition, most of the patients who need IV administration are not (should not be treated as) an outpatient. Therefore, the IV drug use by outpatient clinic cannot be justified in msot cases. In addition, the argument by KMA is not based on the scientific evidence, which they have to pursue. Their blame on the culture in Korea is also unacceptable given that physicians rather than the patients are an expert in medicine. If a patient asks an IV, an informed and learned physician should be able to persuade those patients not to take IV by explaining disadvantages of the IV drugs. Even a patient who has been treated with self-medications purchased from a pharmacy can be safely and effectively treated with oral medications if the patient can be treated as an outpatient as shown in the medical literature. Therefore, the argument seems to be based on emotion not on science and evidence. If they do not practice evidence-based medicine, then the government forces them to do so.

    ´ñ±Û 3 0 0
    • sibalnoma40515
      2005.04.28 13:05:31 ¼öÁ¤ | »èÁ¦
      jos ga tn nom a
    • ÀÌ·¸°Ô40493
      2005.04.28 09:52:13 ¼öÁ¤ | »èÁ¦
      ¾Ë ¾Æ´Â Àΰ£µéÀÌ ¿Ö±×·¡?
    • °¡¹æ²ö40486
      2005.04.28 09:23:39 ¼öÁ¤ | »èÁ¦
      ¿Ü±¹°¡¼­ 'Àå»ç'ÇϼÅ
    µî·Ï
¾à±¹ ÀÏ¹Ý¾à ¸ÅÃâ¾× Top 100(08¿ù)
¼øÀ§ »óǰ¸í Ƚ¼ö
1 ŸÀÌ·¹³îÁ¤500mg(10Á¤) 22292
2 ÄÉÅäÅéÇöó½ºÅ¸(40¸Å) 5135
3 ±î½ºÈ°¸í¼öÅ¥¾× 10440
4 ¸®Áêºñ³Ø½ºÅ©¸² 1096
5 ¾Æ·Î³ª¹Î°ñµåÇÁ¸®¹Ì¾öÁ¤(120Á¤) 1201
6 ¾ÖÅ©³íÅ©¸² 4431
7 ÆÇÇǸ°Å¥¾× 6144
8 ÆÇÄÝ¿¡½º³»º¹¾× 7094
9 ¸á¶óÅä´×Å©¸² 1876
10 º¥Æ÷º§S¿¡½ºÁ¤ 767
11 ³ë½ºÄ«³ª°Ö 20g 2046
12 ÀÕÄ¡ÆäÀ̽ºÆ®Ä¡¾à120g 2887
13 ŸÀÌ·¹³îÁ¤500mg(30Á¤) 4092
14 ʼ¾ ¿¬Áúĸ½¶(10ĸ½¶) 9596
15 ÅÙÅÙÃòÁ¤(120Á¤) 1392
16 ¸Æ½ºÄܵå·ÎÀÌÆ¾1200 268
17 ºñÆÇÅÙ¿¬°í 30g 2696
18 µÑÄÚ¶ô½º-¿¡½ºÀå¿ëÁ¤(40Á¤) 1752
19 ½Å½ÅÆÄ½º¾Æ·º½º ´ëÇü 3669
20 À̰¡Åº¿¡ÇÁĸ½¶(60ĸ½¶*3) 990
21 º£³ªÄ¡¿À¿¡ÇÁ¾×75ml 6478
22 ¾ÖÅ©¸°°Ö 2353
23 ÈĽõò¿¬°í10g 3532
24 ¾Æ·Î³ª¹Î°ñµåÁ¤(100Á¤) 771
25 °Ôº¸¸°Á¤(10Á¤) 4774
26 ±¤µ¿°æ¿Á°í 251
27 ÅÙÅÙÃòÁ¤(10Á¤) 8343
28 ÄÉÆèÇöó½ºÅ¸ 3829
29 µ¿¾ÆD-ÆÇÅ׳°í 2354
30 ±¤µ¿¿ìȲû½É¿øÇöʾ×50ml(¿µ¹¦Çâ) 1427
31 ¸¶µ¥Ä«¼ÖÄɾ°í10g 3237
32 ÀÌÁö¿£6À̺꿬Áúĸ½¶(30ĸ½¶) 2896
33 ʼ¾ ¿¬Áúĸ½¶(30ĸ½¶) 2815
34 ±¤µ¿¿ìȲû½É¿øÇöʾ×50ml(»çÇâ,º¯¹æ) 982
35 ÈĽõò¿¬°í5g 4100
36 ±¤µ¿¿ìȲû½É¿øÈ¯(»çÇâ) 293
37 ÀÕÄ¡ÆäÀ̽ºÆ®ÇÇſġµå150g 1353
38 ¿ÀÅ¥½Ã½ºÁ¡¾È¾×0.5ml*60°³ 1139
39 ¼¾½Ã¾ÆÁ¤(120Á¤) 368
40 Àλ絹Ç÷¯½º(100Á¤) 603
41 ¶ó¹Ì½Ç¿ø½º¿Ü¿ë¾× 1054
42 Áö¸£ÅØÁ¤ 3245
43 À¯ÇѺñŸ¹ÎCÁ¤1000mg 1058
44 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×ÄðÇÏÀÌ ¾÷ 3211
45 ºñ¸Æ½º¸ÞŸºñÁ¤ 349
46 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×Äð ¾÷ 3187
47 Åõ¿¢½ººñÆ®¸®ÇÃÁ¤ 314
48 ÄÝ´ë¿ø ÄÚÇÁÅ¥½Ã·´ 4134
49 ¸Ó½Ã·ÐÁ¤ 1750
50 ¹éÃʽ÷´Ç÷¯½º 2774
51 ½Å½ÅÆÄ½º¾Æ·º½º ÁßÇü 3504
52 ¼¾½Ã¾Æ(180Á¤) 245
53 ¸ÞÀÌŲťÀå¿ëÁ¤(40Á¤) 1527
54 ¸®¾ÈÁ¡¾È¾× 877
55 ¸¶±×ºñ¸Æ½º¿¬Áúĸ½¶ 354
56 ¸¶±×ºñ½ºÇǵå¾× 1423
57 ¸¶µ¥Ä«¼ÖÄɾ°í 6g 3259
58 ½á¹öÄð¾×(50ml)¿ë·®Áõ°¡ 3187
59 ³ë½ºÄ«³ª°Ö10g 1345
60 ÇÁ·»Áî¾ÆÀ̵å·ÓÁ¡¾È¾×¼ø ¾÷ 2680
61 ¸¶µ¥Ä«¼Ö°Ö 1711
62 ÀÕÄ¡ ÇÁ·ÎÆú¸®½º 923
63 ´ÏÄÚ·¹Æ®²­ 2mg (Äð¹ÎÆ®Çâ) 856
64 ³ë½º¿§¼¾½º¾× 1621
65 ¸¶±×ºñ½ºÇÇµå ´õºí¾×¼Ç 1073
66 Ŭ¸®¾îƾ 1249
67 ŸÀÌ·¹³î8½Ã°£À̾˼­¹æÁ¤ 3874
68 ¾ÈƼǪ¶ó¹Î ´õºíÆÄ¿ö ´ëÇü 2032
69 °ÖÆ÷½º¿¤Çöʾ×(6Æ÷) 2111
70 ¿ëÇ¥¿ìȲû½É¿ø¾× 50ml(¹«½ºÄÜ,º¯¹æ) 1150
71 ¹Ù¸£Áö¿À¸ðµÎÅ©¸² 1944
72 ½º¿þÆ®·ÑÆÐµå¾× 750
73 Á¶¾ÆÆË(10¸Å) 1868
74 ÀÌÁö¿£6À̺꿬Áúĸ½¶(10ĸ½¶) 4334
75 ¾ÈƼǪ¶ó¹Î ´õºíÆÄ¿ö ÁßÇü 2156
76 ´ÏÁ¶¶ö2%¾×100ML 724
77 µå¸®Å¬·Î¾×20ml 993
78 ¶ó¶ó¿Ã¶ó¾× 20mL 1441
79 ¿ÀÆ®¸®ºó¸àÅç0.1%ºÐ¹«Á¦ 1072
80 ·Î°ÔÀÎÆû60g(3°³) 166
81 µðÆæÄðÇöó½ºÅ¸(10¸Å) 2271
82 ¾ÆÀ̹̻ê 320
83 ʼ¾·¹À̵ð¿¬Áúĸ½¶ 3119
84 ´ë¿õ¿ì·ç»ç¿¬Áúĸ½¶(120ĸ½¶) 358
85 ´ºº£ÀÎ¾× 592
86 ºñ¸Æ½ºÁ¦Æ®Á¤100Á¤(50T*2) 215
87 ·ÎÅ侾ťºê ¾ÆÄí¾ÆÂ÷Áö12ml 2133
88 ½ºÆ¼¸ð¸°¿¡½ºÅ©¸²10g 1562
89 ¿ëÇ¥¿ìȲû½É¿ø¾×50ml(»çÇâ,º¯¹æ) 667
90 ¹«Á¶³¯¸Æ½º¿Ü¿ë¾×(Å׸£ºñ³ªÇÉ)³×À϶óÄ« 574
91 ¾ÆÁ©¸®¾ÆÅ©¸²30g 506
92 Àλ絹Á¤(100Á¤) 442
93 ÆÇ½Ãµôĸ½¶(270ĸ½¶) 126
94 ¾×Ƽ¸®¹ö¸ð´×¿¬Áúĸ½¶ 237
95 ÀÌÁö¿£6ÇÁ·Î¿¬Áúĸ½¶(30ĸ½¶) 1460
96 èÇÁ½Ã·´ 2213
97 ºñÆÇÅÙ¿¬°í 100g 441
98 Àλ絹Ç÷¯½ºÁ¤(270Á¤) 163
99 Å©¸°Å¬¸ê±Õ»ý¸®½Ä¿°¼ö20ml*20¾ÚÇà 1175
100 ÄÚ¾ØÄ𠳪Àß½ºÇÁ·¹ÀÌ 1067
Àüüº¸±â
ÁÖ¹®½Ã °áÁ¦±Ý¾×ÀÇ 5% Áï½Ã ÇÒÀÎ!

ÀÎÅͳݽŹ®µî·Ï¹øÈ£: ¼­¿ï,¾Æ52715 | µî·ÏÀÏÀÚ 2019.11.20 | ¹ßÇàÀÏÀÚ 2019.11.20 | ¹ßÇàÀÎ : ÀÌÁ¤¼® | ÆíÁýÀÎ : °¡ÀÎÈ£
¹ßÇàÁÖ¼Ò: ¼­¿ï½Ã ¼ÛÆÄ±¸ ¹ý¿ø·Î 128 ¹®Á¤ SK V1 GL ¸ÞÆ®·Î½ÃƼ Aµ¿ 401È£
ÀüÈ­ : 02-3473-0833 |ÆÑ½º : 02-3474-0169 | û¼Ò³âº¸È£Á¤Ã¥(Ã¥ÀÓÀÚ °­½Å±¹)
Contact dailypharm@dailypharm.com for more information
µ¥Àϸ®ÆÊÀÇ ¸ðµç ÄÜÅÙÃ÷(±â»ç)¸¦ ¹«´Ü »ç¿ëÇÏ´Â °ÍÀº ÀúÀ۱ǹý¿¡ ÀúÃ˵Ǹç, ¹ýÀû Á¦À縦 ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.